In order to examine the structureactivity relationship between the platinum complexes having a bidentate ligand as non-leaving group dichloro 2aminomethylpiperidine Pt(II), PtCla(2ampip) dichloro 3-aminomethylpiperidine Pt(II), PtCla-(3ampip), and dichloro 2aminomethylpyridine Pt(II), PtClz(2-ampy),
Synthesis and antitumor activity of DNA binding cationic porphyrin–platinum(II) complexes
✍ Scribed by Rita Song; Yeong-Sang Kim; Chong Ock Lee; Youn Soo Sohn
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- French
- Weight
- 140 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
✦ Synopsis
A new series of DNA binding 5,10,15-tri(N-methyl-4-pyridiniumyl)porphyrin (TrisMPyP)-platinum(II) conjugates was synthesized, in which different spacer ligands were used for appropriate coordination to platinum(II) complexes. Compound 9b exhibited in vivo antitumor activity (T/C%, 294) superior to cisplatin (T/C%, 184) against the leukemia L1210 cell line.
📜 SIMILAR VOLUMES
The presence of Ca 2+ has a marked effect on the reaction release of the phosphonate ligand as observed by NMR is significantly accelerated by the presence of Ca 2+ , which is kinetics of platinum phosphonate complexes with d(GpG). Compounds studied are [cis-Pt(NH 3 ) 2 (bmpaa)] and [Pt(R,S-ascribed